Results 131 to 140 of about 4,325,962 (256)

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

Journal of Clinical Investigation, 2017
P. Beavis, M. Henderson, Lauren Giuffrida, J. K. Mills, K. Sek, R. Cross, A. Davenport, Liza B. John, Sherly Mardiana, C. Slaney, R. Johnstone, J. Trapani, J. Stagg, S. Loi, L. Kats, D. Gyorki, M. Kershaw, P. Darcy   +17 more
semanticscholar   +1 more source

Adenosine Receptors

Biochimica et Biophysica Acta (BBA) - Biomembranes, 2011
openaire   +2 more sources

A2A adenosine receptor-mediated increase in coronary flow in hyperlipidemic APOE–knockout mice

, 2011
Bunyen Teng, S Jamal MustafaDepartment of Physiology and Pharmacology and Center for Cardiovascular and Respiratory Sciences, West Virginia University, Morgantown, WV, USAAbstract: Adenosine-induced coronary vasodilation is predominantly A2A adenosine ...
Mustafa SJ, Teng B
core  

The A3 Adenosine Receptor: History and Perspectives

Pharmacological Reviews, 2015
P. Borea, K. Varani, F. Vincenzi, P. Baraldi, M. Tabrizi, S. Merighi, S. Gessi   +6 more
semanticscholar   +1 more source

Thermodinamic Analysis in Drug-receptor Binding: The A3 Adenosine receptor

, 2010
Receptor binding thermodynamics is a powerful tool to gain deep insight, at the molecular level, of the events which occur during drug-receptor interactions.
GESSI, Stefania, BOREA, Pier Andrea, VARANI, Katia, MERIGHI, Stefania   +3 more
core  

Loss of caveolar A1 adenosine receptor signalling blunts anti-adrenergic control in heart failure. [PDF]

Cardiovasc Res
Mazzola M, Wang H, Lang D, Balycheva M, Bhogal N, Sanchez-Alonso JL, Diakonov I, Lucarelli C, Lai EC, Punjabi PP, Miragoli M, Faggian G, Glukhov AV, Gorelik J.   +13 more
europepmc   +1 more source

Adenosine Receptor 3 Antagonism Suppresses Adipogenesis via the EREG-EGFR-Leptin Axis in Multipotent Cells. [PDF]

Biofactors
Lee CH, Tseng KY, Lin FH, Wu HM, Lin S.
europepmc   +1 more source

Adenosine Receptor Functionality and Desensitization Machinery in a Neuronal Cell Model of Angelman Syndrome. [PDF]

J Dev Biol
Contestabile M, Martins de Almeida JF, De Cesari C, Tonazzini I, Artini PG, Daniele S.   +5 more
europepmc   +1 more source

The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist. [PDF]

Int J Obes (Lond)
Fishman P, Itzhak I, Safadi R, Amer J, Salhab A, Bareket-Samish A.   +5 more
europepmc   +1 more source

Correction: Unlocking the adenosine receptor mechanism of the tumour immune microenvironment. [PDF]

Front Immunol
Han Y, Dong C, Hu M, Wang X, Wang G.
europepmc   +1 more source